GlassScriptPhysician profile
Andrew J Gray
NPI 1407341464
$2,095.30
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $114 · 2021: $14.20 · 2022: $164 · 2023: $339 · 2024: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725 · Travel and Lodging: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.04 |
| Travel and Lodging | $708.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $960.34 | 2024 | Ruby Coil |
| Janssen Scientific Affairs, LLC | $237.50 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $234.10 | 2022-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $149.99 | 2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Vifor Pharma, INC. | $121.84 | 2019 | |
| Medtronic, INC. | $107.10 | 2022 | |
| Shockwave Medical, INC | $30.04 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $28.24 | 2024 | Halo One Thin-Walled Guiding Sheath |
| Lantheus Medical Imaging, INC. | $27.03 | 2022 | |
| Abiomed | $23.35 | 2023 | Impella |
| Abbott Laboratories | $20.26 | 2022 | |
| Pfizer INC. | $16.31 | 2023 | |
| Terumo Medical Corporation | $14.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.